Synpromics Ltd company

Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.
Technology: Regenerative Medicine
Industry: Personalized Medicine
Headquarters: Edinburgh, Edinburgh, City of, United Kingdom
Founded Date: 2010
Employees Number: 1-10
Funding Status: N/A
Investors Number: 3
Total Funding: £9.2M
Estimated Revenue: $1M to $10M
Last Funding Type: Grant

Visit Website
Register and Claim Ownership